: : : 2007-06-11 to 2007-06-17
Public Health Advisory: Gadolinium-containing Contrast Agents
June 15, 2007 12:39
June 8, 2006--The FDA learned of 25 cases of NSF/NFD in patients with kidney failure who received Omniscan®, a gadolinium-containing contrast agent, and took the MRA test. The FDA is actively investigating whether exposure to a gadolinium-contrast agent for... (Read Article)
